oxatomide has been researched along with butylscopolammonium bromide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Arita, K; Natsuga, K; Shimizu, H; Shimizu, T; Tomizawa, K; Ujiie, H | 1 |
3 other study(ies) available for oxatomide and butylscopolammonium bromide
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Severe cholinergic urticaria successfully treated with scopolamine butylbromide in addition to antihistamines.
Topics: Adult; Butylscopolammonium Bromide; Drug Therapy, Combination; Exercise; Famotidine; Histamine H1 Antagonists; Histamine H2 Antagonists; Hot Temperature; Humans; Hydroxyzine; Male; Muscarinic Antagonists; Piperazines; Urticaria | 2006 |